top of page
Search


Samso News: Cyprium Metals Limited — A$41m Equity Raising Advances Nifty Restart and Regional Copper Growth - Tracking the Transition to Near-Term Copper Production.
Cyprium Metals Limited (ASX: CYM) has announced a A$41 million equity capital raising to accelerate regional exploration and production growth initiatives across its Paterson and Murchison copper portfolio. The funding supports the phased restart of the Nifty Copper Complex in Western Australia (Figure 1), where first cathode production is targeted for mid-2026, while also advancing studies for future expansion and satellite feed opportunities.

Noel Ong
Jan 266 min read


Pivotal Metals – Multiple Gold & Copper Targets Defined at Lorraine – A District-Scale Cu-Ni-Au Exploration Leverage - Decent Looking Targets - Cautious DYOR Required.
Samso is drawn to Pivotal Metals because the Company is applying systematic, district-scale geophysics to expand known high-grade mineral systems rather than relying on isolated drill targets. The combination of historic production, bonanza-grade gold intersections, and newly defined geophysical anomalies creates a technically coherent exploration narrative that is supported by infrastructure and jurisdictional advantages in Québec.

Noel Ong
Jan 237 min read


Samso News: Firebird Metals – LMR Cathode Equipment Commissioned – A Vertically Integrated Manganese story that is Driven with A Battery Materials Optionality.
Firebird Metals Limited (ASX: FRB) has completed the installation and commissioning of its proprietary cathode active materials (CAM) equipment at its wholly owned China pilot plant, marking a key step in advancing lithium-manganese-rich (LMR) cathode development. The milestone supports Firebird’s vertically integrated ore-to-cathode strategy, with initial LMR CAM production scheduled to commence in February 2026 and customer sampling planned for the second half of 2026.

Noel Ong
Jan 236 min read


Samso News: NeuroScientific Biopharmaceuticals Limited – StemSmart™ Delivers Clinical Responses in Fistulising Crohn’s Disease – Time for understaing when to take your position.
Samso is drawn to NeuroScientific because the Company is transitioning from early-stage development into real-world clinical validation. The Special Access Program outcomes represent a tangible inflection point, where clinical efficacy, regulatory engagement, and manufacturing readiness begin to converge around a scalable therapeutic platform.

Noel Ong
Jan 238 min read


Samso News: ReNerve Limited — A Peripheral Nerve Injury Story – Too Early To Take A Position?
ReNerve Limited has secured market registration approval in Malaysia for its NervAlign® Nerve Cuff, marking another regulatory milestone in the Company’s Asia-Pacific expansion strategy. The approval adds to existing clearances in Hong Kong and Thailand and follows a positive assessment of ReNerve’s clinical evaluation data. With an established US commercial base and a growing portfolio of nerve repair and tissue products.

Noel Ong
Jan 217 min read


Samso News: Western Yilgarn Limited— Secures Expanded Land Access at West Julimar - Growing a Scalable Bauxite Resource Base.
Western Yilgarn NL (ASX: WYX) has executed new land access agreements over Zones 100 and 200 at its West Julimar Bauxite Project in the Darling Range of Western Australia (Figure 1). These agreements provide access to extensive areas of lateritic bauxite immediately adjoining and between the Company’s existing JORC-compliant Mineral Resource areas, opening a clear pathway for potential resource expansion.

Noel Ong
Jan 216 min read


Samso News: Terra Critical Minerals — Closes Acquisition of the High-Grade True American Tungsten Project in Nevada, USA - A US Focused Tungsten Optionality.
Terra Critical Minerals Limited (ASX: T92) has closed the acquisition of the 100%-owned True American Tungsten Project, located in central Nevada, USA. The transaction marks Terra’s formal entry into the U.S. tungsten space, securing a historically high-grade project within a recognised mining jurisdiction and positioning the Company for on-the-ground work programs in 2026.

Noel Ong
Jan 216 min read


Island Pharmaceuticals Strengthens Galidesivir Position with New US Filoviridae Patent - An Antiviral Solution for your Watchlist.
Island Pharmaceuticals Limited (ASX: ILA) is advancing its antiviral strategy through the clinical development of Galidesivir, a broad-spectrum antiviral targeting high-consequence viral threats, including Marburg and Ebola. The program is positioned within a global biosecurity and public health framework, with regulatory engagement centred on the United States Food and Drug Administration (FDA) and potential inclusion in government stockpiles.

Noel Ong
Jan 207 min read


IRIS Metals – High-Grade Rubidium Discovery Strengthens Beecher as a U.S. Critical Minerals Asset – Is this the next Critical Metal Conversation?
IRIS Metals Limited (ASX: IR1) has reported high-grade rubidium assay results from its 2023 and 2024 drilling programs at the Beecher Project, located in the southern Black Hills of South Dakota, USA (Figure 1). The results confirm a significant rubidium discovery alongside the project’s established lithium resource, further positioning Beecher as a multi-commodity critical minerals asset in a mining-friendly U.S. jurisdiction.

Noel Ong
Jan 197 min read


Samso Insights: Prominent Hill vs Carrapateena — Two Discoveries That May Signal That The Gawler Craton Is Hiding Hybrid-IOCG like a Palabora - Saloboi or Candelaria.
When we talk about modern mineral discoveries in Australia, two names inevitably surface in the same breath: Prominent Hill and Carrapateena. Both sit in South Australia’s Gawler Craton, both are world-class Iron Oxide Copper-Gold (IOCG) systems, and both ended up becoming cornerstone assets for OZ Minerals, now part of BHP. But lumping them together as “IOCG discoveries” misses the deeper story.

Noel Ong
Jan 1811 min read
bottom of page
